Pantoprazol Sun (Pantoprazole)

Pantoprazole, the active ingredient in Pantoprazol Sun, is a proton pump inhibitor presented as a 40 mg tablet for oral use. It reduces stomach acid production and is used to treat acid‑related disorders such as gastro‑oesophageal reflux disease and peptic ulcer disease in adults.

GNH USA supplies Pantoprazol Sun as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Pantoprazol Sun is a proton pump inhibitor that acts on the gastric acid secretion pathway. It is indicated for several acid‑related conditions: - Gastro‑oesophageal reflux disease (GERD): provides symptomatic relief and promotes healing of the oesophageal lining. - Erosive oesophagitis: heals erosions and prevents further damage. - Peptic ulcer disease: supports ulcer healing and reduces recurrence risk. - Zollinger‑Ellison syndrome: controls excessive gastric acid production. - Helicobacter pylori eradication regimens: used as part of combination therapy to improve eradication rates.

Pantoprazol Sun may cause a range of adverse reactions. Monitoring patients for both common and serious events is recommended.

Common Side Effects: - Headache: mild to moderate intensity. - Diarrhoea: usually self‑limiting. - Nausea: occasional, may improve with food. - Abdominal pain: mild discomfort. - Flatulence: excess gas. - Constipation: reduced bowel movements.

Serious or Rare Side Effects: - Severe allergic reaction (anaphylaxis): rash, swelling, difficulty breathing. - Clostridioides difficile infection: persistent watery diarrhoea. - Low magnesium levels (hypomagnesemia): muscle cramps, irregular heartbeat. - Bone fractures: increased risk with long‑term use. - Acute interstitial nephritis: kidney inflammation. - Liver enzyme elevation: signs of hepatic stress.

Before initiating Pantoprazol Sun, consider the following safety measures: - Assess renal function: dose adjustment may be needed in severe impairment. - Review liver status: use with caution in hepatic disease. - Evaluate need for long‑term therapy: prolonged use is linked to fracture risk. - Monitor electrolytes: especially magnesium during extended treatment. - Avoid abrupt discontinuation: taper to reduce rebound acid hypersecretion. - Store at ambient temperature: keep below 25 °C, in the original container, protected from moisture.

Pantoprazol Sun can affect the plasma concentrations of several co‑administered medicines. Interaction management is essential.

Major Interactions (Avoid): - Antifungal azoles (ketoconazole, itraconazole): reduced absorption due to increased gastric pH. - HIV protease inhibitors (atazanavir, nelfinavir): decreased efficacy. - Clopidogrel: diminished antiplatelet effect.

Moderate Interactions (Monitor Closely): - Warfarin: potential increase in INR; monitor coagulation. - Methotrexate: higher systemic exposure, especially at high doses. - Digoxin: modest rise in serum levels; check renal function.